Shares of Teladoc Health Inc. TDOC are trading lower today following an analyst downgrade.
Why Is It Moving?
Shares are down after Guggenheim downgraded the stock from Neutral to Sell and lowered its price target to $25. The firm reportedly cited slowing growth following the company's pandemic-driven boom.
This reportedly marks Teladoc’s first sell rating from a Wall Street analyst and it seems to be worrying investors.
TDOC Price Action: Shares are down 6.55% at $36.87 during Wednesday's premarket trading session, according to Benzinga Pro.
Photo: Courtesy of the National Cancer Institute on Unsplash
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.